Monthly Publications
In Depth
Subscribe Now
In Depth
coverage of timely
Life Science
Compliance issues
Subscribe Now
Browsing Category
Pharmaceutical and Device
New Research Paper Indicates Price Transparency May Not Equate to Lower…
Last June, President Donald Trump signed an Executive Order on Improving Price and Quality Transparency in American Healthcare to…
CMS Proposes New Coverage Pathway for Medical Devices
On August 31, 2020, the Centers for Medicare and Medicaid Services (CMS) released a proposed rule that would create a new pathway…
Prior Authorization Changes Driven by the COVID-19 Pandemic
By Robert Popovian & Amanda DeMarzo
Many hospitals have shifted staff resources from administrative functions to direct…
Drugs Being Approved with Fewer Trials?
According to a study recently published in JAMA Network Open, more recent drug and biologic approvals by the United States Food…
Consumers’ Impression of Pharma Is More Favorable Now
We have long heard about the negative impression Americans had of the pharmaceutical industry. However, a recent Harris Poll may…
Does Pharma Hold the Key to a COVID-19 Solution?
A frequent refrain we hear on the news these days is whether there are medicines and other potential solutions to help Americans…
Coronavirus and the Pharmaceutical Supply Chain
The novel coronavirus (also known as COVID-19) has been dominating the news media coverage these last few weeks. We don’t know…
Biopharmaceutical Industry Addressing Coronavirus
Members of the Pharmaceutical Research and Manufacturers of America (PhRMA) are making strides to address the coronavirus…
Blue Cross Blue Shield Invests in Nonprofit Aimed at Cheaper Drugs
The Blue Cross Blue Shield Association (BCBSA) and eighteen of its member organizations have agreed to invest $55 million in a…
Oncologists Rely on Pharma Reps for Information
Despite the bad rap drug representatives seem to get, a recent survey done by Cardinal Health Specialty Solutions found that…